Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Minocycline protects motor but not autonomic neurons after cauda equina injury.

Hoang TX, Akhavan M, Wu J, Havton LA.

Exp Brain Res. 2008 Jul;189(1):71-7. doi: 10.1007/s00221-008-1398-5. Epub 2008 May 14.

2.

Limited minocycline neuroprotection after balloon-compression spinal cord injury in the rat.

Saganová K, Orendácová J, Cízková D, Vanický I.

Neurosci Lett. 2008 Mar 15;433(3):246-9. doi: 10.1016/j.neulet.2008.01.041. Epub 2008 Jan 20.

PMID:
18280653
3.

Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.

Nagel S, Su Y, Horstmann S, Heiland S, Gardner H, Koziol J, Martinez-Torres FJ, Wagner S.

Brain Res. 2008 Jan 10;1188:198-206. Epub 2007 Nov 26.

PMID:
18031717
4.

Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury.

Yune TY, Lee JY, Jung GY, Kim SJ, Jiang MH, Kim YC, Oh YJ, Markelonis GJ, Oh TH.

J Neurosci. 2007 Jul 18;27(29):7751-61.

5.

Minocycline as a neuroprotective agent.

Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W.

Neuroscientist. 2005 Aug;11(4):308-22. Review.

PMID:
16061518
6.

Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion.

Fox C, Dingman A, Derugin N, Wendland MF, Manabat C, Ji S, Ferriero DM, Vexler ZS.

J Cereb Blood Flow Metab. 2005 Sep;25(9):1138-49. Erratum in: J Cereb Blood Flow Metab. 2006 Mar;26(3):446.

7.

The promise of minocycline in neurology.

Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM.

Lancet Neurol. 2004 Dec;3(12):744-51. Review.

PMID:
15556807
8.

Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model.

Tsuji M, Wilson MA, Lange MS, Johnston MV.

Exp Neurol. 2004 Sep;189(1):58-65.

PMID:
15296836
9.

Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease.

Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F.

Eur J Neurosci. 2004 Jun;19(12):3266-76.

PMID:
15217383
10.

Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection.

Fagan SC, Edwards DJ, Borlongan CV, Xu L, Arora A, Feuerstein G, Hess DC.

Exp Neurol. 2004 Apr;186(2):248-51.

PMID:
15026261
11.

Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB, Steeves JD, Ramer MS, Tetzlaff W.

J Neurosci. 2004 Mar 3;24(9):2182-90.

12.

Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury.

Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME, Friedlander RM.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3071-6. Epub 2004 Feb 23.

13.

Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat.

Lee SM, Yune TY, Kim SJ, Park DW, Lee YK, Kim YC, Oh YJ, Markelonis GJ, Oh TH.

J Neurotrauma. 2003 Oct;20(10):1017-27.

PMID:
14588118
14.

Minocycline enhances MPTP toxicity to dopaminergic neurons.

Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS.

J Neurosci Res. 2003 Oct 15;74(2):278-85.

PMID:
14515357
15.
16.

Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice.

Wells JE, Hurlbert RJ, Fehlings MG, Yong VW.

Brain. 2003 Jul;126(Pt 7):1628-37. Epub 2003 Jun 4.

PMID:
12805103
17.

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM.

Nature. 2002 May 2;417(6884):74-8.

PMID:
11986668
18.

Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction.

Sanchez Mejia RO, Ona VO, Li M, Friedlander RM.

Neurosurgery. 2001 Jun;48(6):1393-9; discussion 1399-401.

PMID:
11383749
19.

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J.

J Neurosci. 2001 Apr 15;21(8):2580-8.

20.

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.

Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM.

Nat Med. 2000 Jul;6(7):797-801.

PMID:
10888929

Supplemental Content

Support Center